Moreover, growing data show that the modulatory actions of platelet factors such as EGF (epidermal growth factor), IGF-I (insulin-growth factor-I), TGF-β (transforming growth factor beta), PDGF and VEGF (vascular endothelial growth factor) alter the cancer chemotherapy sensitivity or resistance [47]. This evidence concerns the gene EGF and cancer.